My Treatment Approach to Patients With Diffuse Large B-Cell LymphomaARMITAGE, James O.Mayo Clinic proceedings. 2012, Vol 87, Num 2, pp 161-171, issn 0025-6196, 11 p.Article

How I treat patients with diffuse large B-cell lymphomaARMITAGE, James O.Blood. 2007, Vol 110, Num 1, pp 29-36, issn 0006-4971, 8 p.Article

The aggressive peripheral T-cell lymphomas: 2012 Update on diagnosis, risk stratification, and managementARMITAGE, James O.American journal of hematology. 2012, Vol 87, Num 5, pp 512-519, issn 0361-8609, 8 p.Article

Positron Emission Tomographic Scans in Lymphoma: Convention and ControversyANSELL, Stephen M; ARMITAGE, James O.Mayo Clinic proceedings. 2012, Vol 87, Num 6, pp 571-580, issn 0025-6196, 10 p.Article

Management of hodgkin lymphomaANSELL, Stephen M; ARMITAGE, James O.Mayo Clinic proceedings. 2006, Vol 81, Num 3, pp 419-426, issn 0025-6196, 8 p.Article

From targets to therapy: novel drugs in advanced clinical trialsARMITAGE, James O; SPRIGGS, David R.Seminars in oncology. 2004, Vol 31, Num 6, issn 0093-7754, 38 p., SUP16Serial Issue

Non-Hodgkin lymphomaSHANKLAND, Kate R; ARMITAGE, James O; HANCOCK, Barry W et al.Lancet (British edition). 2012, Vol 380, Num 9844, pp 848-857, issn 0140-6736, 10 p.Article

The proteasomeDALTON, William S.Seminars in oncology. 2004, Vol 31, Num 6, pp 3-9, issn 0093-7754, 7 p., SUP16Article

Unraveling biologic therapy for Bcl-2-expressing malignanciesCOTTER, Finbarr E.Seminars in oncology. 2004, Vol 31, Num 6, pp 18-21, issn 0093-7754, 4 p., SUP16Article

Clinical update: Novel targets in multiple myelomaANDERSON, Kenneth C.Seminars in oncology. 2004, Vol 31, Num 6, pp 27-32, issn 0093-7754, 6 p., SUP16Article

Colony-Stimulating Factors for Febrile Neutropenia during Cancer TherapyBENNETT, Charles L; DJULBEGOVIC, Benjamin; NORRIS, Leann B et al.The New England journal of medicine. 2013, Vol 368, Num 12, pp 1131-1139, issn 0028-4793, 9 p.Article

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximabPERRY, Anamarija M; ALVARADO-BERNAL, Yuridia; CHAN, Wing C et al.British journal of haematology. 2014, Vol 165, Num 3, pp 382-391, issn 0007-1048, 10 p.Article

B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: study of 39 casesPERRY, Anamarija M; CROCKETT, David; BIERMAN, Phillip et al.British journal of haematology. 2013, Vol 162, Num 1, pp 40-49, issn 0007-1048, 10 p.Article

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma ProjectWEISENBURGER, Dennis D; SAVAGE, Kerry J; CAMPO, Elias et al.Blood. 2011, Vol 117, Num 12, pp 3402-3408, issn 0006-4971, 7 p.Article

The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary componentABUZETUN, Jamil Y; LOBERIZA, Fausto; VOSE, Julie et al.British journal of haematology. 2009, Vol 144, Num 4, pp 531-537, issn 0007-1048, 7 p.Article

Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphomaVOSE, Julie M; BIERMAN, Philip J; ENKE, Charles et al.Journal of clinical oncology. 2005, Vol 23, Num 3, pp 461-467, issn 0732-183X, 7 p.Article

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival predictionBEA, Silvia; ZETTL, Andreas; LOPEZ-GUILLERMO, Armando et al.Blood. 2005, Vol 106, Num 9, pp 3183-3190, issn 0006-4971, 8 p.Article

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphomaIQBAL, Javeed; SANGER, Warren G; SHERMAN, Simon et al.The American journal of pathology. 2004, Vol 165, Num 1, pp 159-166, issn 0002-9440, 8 p.Article

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphomaVAN BESIEN, Koen; LOBERIZA, Fausto R; MARKS, David I et al.Blood. 2003, Vol 102, Num 10, pp 3521-3529, issn 0006-4971, 9 p.Article

CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphomaMITROVIC, Zdravko; IQBAL, Javeed; CHAN, Wing C et al.British journal of haematology. 2013, Vol 162, Num 1, pp 87-92, issn 0007-1048, 6 p.Article

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma : a study of 136 cases from the International Peripheral T-Cell Lymphoma ProjectAU, Wing-Yan; WEISENBURGER, Dennis D; INTRAGUMTORNCHAI, Tanin et al.Blood. 2009, Vol 113, Num 17, pp 3931-3937, issn 0006-4971, 7 p.Article

ALK^-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK⁺ ALCL and peripheral T-cell lymphoma, not otherwise specified : report from the International Peripheral T-Cell Lymphoma ProjectSAVAGE, Kerry J; LEE HARRIS, Nancy; ARMITAGE, James O et al.Blood. 2008, Vol 111, Num 12, pp 5496-5504, issn 0006-4971, 9 p.Article

Point mutations and genomic deletions in CCND1 create stable truncated cyclin dl mRNAs that are associated with increased proliferation rate and shorter survivalWIESTNER, Adrian; TEHRANI, Mahsa; CHAN, Wing C et al.Blood. 2007, Vol 109, Num 11, pp 4599-4606, issn 0006-4971, 8 p.Article

Outcomes After Hematopoietic Stem-Cell Transplantation for Hematologic Malignancies in Patients With or Without Advance Care PlanningKISHOR GANTI, Apar; LEE, Stephanie J; VOSE, Julie M et al.Journal of clinical oncology. 2007, Vol 25, Num 35, pp 5643-5648, issn 0732-183X, 6 p.Article

Molecular diagnosis of Burkitt's lymphomaDAVE, Sandeep S; KAI FU; MÜLLER-HERMELINK, Hans-Konrad et al.The New England journal of medicine. 2006, Vol 354, Num 23, pp 2431-2442, issn 0028-4793, 12 p.Article